« Previous Next » Journal of Vascular Surgery
Volume 47, Issue 1 , Pages 55-62 , January 2008

The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability

Presented at the 2007 Vascular Annual Meeting, Baltimore, Md, Jun 6-10, 2007.

Nikolaos P.E. Kadoglou, MD, MSc
- Department of Vascular Surgery, Medical School, University of Athens, Athens, Greece
- First Department of Internal Medicine, “Hippokratio” General Hospital, Thessaloniki, Greece
- Correspondence: Nikolaos P. E. Kadoglou, MD, MSc, 124 Vosporou str, 54454 Thessaloniki Greece.
Thomas Gerasimidis, MD
- Fifth Surgical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
Spyretta Golemati, PhD
- Department of Vascular Surgery, Medical School, University of Athens, Athens, Greece
Alkistis Kapelouzou, BSc
- Foundation of Biomedical Research, Center for Experimental Surgery, Academy of Athens, Athens, Greece.
Panayiotis E. Karayannacos, MD, FACS
- Foundation of Biomedical Research, Center for Experimental Surgery, Academy of Athens, Athens, Greece.
Christos D. Liapis, MD, FACS, FRCS
- Department of Vascular Surgery, Medical School, University of Athens, Athens, Greece

Received 4 June 2007 ,Accepted 20 September 2007.

Serum OPN and OPG concentrations in symptomatic, asymptomatic, and healthy control group. A, Symptomatic group. B, Asymptomatic group. C, Healthy individuals.

Serum OPN and OPG concentrations in symptomatic, asymptomatic, and healthy control group. A, Symptomatic group. B, Asymptomatic group. C, Healthy individuals.
- Full-Size Image
- Download to PowerPoint